Chemed Analyst Price Targets

Chemed Corp

CHENYSE

$519.01

-0.83-0.16%

가까이에: Sep 8, 5:00 PM EST

$519.00

-0.010%

시간외: 5:23 PM EST

Wall Street analyst price targets and consensus rating for Chemed (CHE).

Price Target Range — 11 Quarters

Analyst Consensus — 4 Analysts

1Buy

3Hold

Consensus RatingOutperform# Analysts4Avg. Consensus PT$531Upside to Avg. PT+2.3%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 31, 2026	Oppenheimer	Michael Wiederhorn	PT Raise	Outperform	$500→$590
Jul 30, 2026	RBC Capital	Ben Hendrix	PT Raise	Sector Perform	$436→$548
Jul 9, 2026	B of A Securities	Joanna Gajuk	PT Raise	Neutral	$450→$510
Apr 27, 2026	RBC Capital	Ben Hendrix	PT Raise	Sector Perform	$422→$436
Feb 27, 2026	RBC Capital	Ben Hendrix	Downgrade	Outperform→Sector Perform	$572→$422
Feb 27, 2026	Oppenheimer	Michael Wiederhorn	PT Cut	Outperform	$580→$500
Jan 22, 2026	Jefferies	Brian Tanquilut	Downgrade	Buy→Hold	$550→$475
Nov 10, 2025	RBC Capital	Ben Hendrix	PT Cut	Outperform	$589→$572
Sep 10, 2025	B of A Securities	Joanna Gajuk	PT Cut	Buy	$610→$595
Sep 2, 2025	Jefferies	Brian Tanquilut	Upgrade	Hold→Buy	$490→$550
Jul 31, 2025	RBC Capital	Ben Hendrix	PT Cut	Outperform	$640→$589
Jul 31, 2025	Oppenheimer	Michael Wiederhorn	PT Cut	Outperform	$650→$580
Jul 25, 2025	Jefferies	Brian Tanquilut	Initiate	Hold	$500
Jun 30, 2025	RBC Capital	Ben Hendrix	PT Cut	Outperform	$674→$640
Jun 30, 2025	B of A Securities	Joanna Gajuk	PT Cut	Buy	$708→$650
Apr 28, 2025	RBC Capital	Ben Hendrix	PT Raise	Outperform	$667→$674
Mar 14, 2025	RBC Capital	Ben Hendrix	PT Raise	Outperform	$633→$667
Nov 5, 2024	RBC Capital	Ben Hendrix	PT Cut	Outperform	$697→$633
May 21, 2024	RBC Capital	Ben Hendrix	PT Cut	Outperform	$712→$697
Mar 4, 2024	RBC Capital	Ben Hendrix	PT Raise	Outperform	$604→$712